These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36127363)

  • 41. A-to-I editing of Malacoherpesviridae RNAs supports the antiviral role of ADAR1 in mollusks.
    Rosani U; Bai CM; Maso L; Shapiro M; Abbadi M; Domeneghetti S; Wang CM; Cendron L; MacCarthy T; Venier P
    BMC Evol Biol; 2019 Jul; 19(1):149. PubMed ID: 31337330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADAR1 Editing and its Role in Cancer.
    Xu LD; Öhman M
    Genes (Basel); 2018 Dec; 10(1):. PubMed ID: 30585209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics.
    Nakano M; Nakajima M
    Pharmacol Ther; 2018 Jan; 181():13-21. PubMed ID: 28716651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
    Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
    J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications.
    Weng S; Yang X; Yu N; Wang PC; Xiong S; Ruan H
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.
    Freund EC; Sapiro AL; Li Q; Linder S; Moresco JJ; Yates JR; Li JB
    Cell Rep; 2020 May; 31(7):107656. PubMed ID: 32433965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer.
    Goncharov AO; Kliuchnikova AA; Nasaev SS; Moshkovskii SA
    Biochemistry (Mosc); 2019 Aug; 84(8):896-904. PubMed ID: 31522671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Artificial RNA Editing with ADAR for Gene Therapy.
    Bhakta S; Tsukahara T
    Curr Gene Ther; 2020; 20(1):44-54. PubMed ID: 32416688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenosine-to-Inosine RNA Editing in Health and Disease.
    Gatsiou A; Vlachogiannis N; Lunella FF; Sachse M; Stellos K
    Antioxid Redox Signal; 2018 Sep; 29(9):846-863. PubMed ID: 28762759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
    Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mouse models to elucidate the functional roles of adenosine-to-inosine editing.
    Rula EY; Emeson RB
    Methods Enzymol; 2007; 424():333-67. PubMed ID: 17662849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets.
    Forni D; Mozzi A; Pontremoli C; Vertemara J; Pozzoli U; Biasin M; Bresolin N; Clerici M; Cagliani R; Sironi M
    RNA Biol; 2015; 12(2):149-61. PubMed ID: 25826567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADAR1 and ADAR2 expression and editing activity during forebrain development.
    Jacobs MM; Fogg RL; Emeson RB; Stanwood GD
    Dev Neurosci; 2009; 31(3):223-37. PubMed ID: 19325227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenosine-to-inosine RNA editing and human disease.
    Slotkin W; Nishikura K
    Genome Med; 2013; 5(11):105. PubMed ID: 24289319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteomic Analysis of Zebrafish Protein Recoding via mRNA Editing by ADAR Enzymes.
    Nasaev SS; Kopeykina AS; Kuznetsova KG; Levitsky LI; Moshkovskii SA
    Biochemistry (Mosc); 2022 Nov; 87(11):1301-1309. PubMed ID: 36509721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
    Liao Y; Jung SH; Kim T
    Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The origin of the ADAR gene family and animal RNA editing.
    Grice LF; Degnan BM
    BMC Evol Biol; 2015 Jan; 15(1):4. PubMed ID: 25630791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
    Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
    Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.